L. Aïssi-rothé, V. Decot, V. Venard, H. Jeulin, A. Salmon et al., Rapid generation of full clinical-grade human antiadenovirus cytotoxic T cells for adoptive immunotherapy, J. Immunother. Hagerstown Md, vol.33, pp.414-424, 1997.

H. Akiyama, T. Kurosu, C. Sakashita, T. Inoue, . Mori-si et al., Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.32, 2001.

A. Qurashi, Y. M. Guiver, M. Cooper, and R. J. , Sequence typing of adenovirus from samples from hematological stem cell transplant recipients, J. Med. Virol, vol.83, pp.1951-1958, 2011.

K. A. Aldern, S. L. Ciesla, K. L. Winegarden, and K. Y. Hostetler, Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism, Mol. Pharmacol, vol.63, pp.678-681, 2003.

L. B. Allen, K. H. Boswell, T. A. Khwaja, R. B. Meyer, R. W. Sidwell et al., Synthesis and antiviral acticity of some phosphates of the broad-spectrum antiviral nucleoside, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin), J. Med. Chem, vol.21, pp.742-746, 1978.

G. Andrei, R. Snoeck, J. Piette, P. Delvenne, and E. De-clercq, Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines, Oncol. Res, vol.10, pp.523-531, 1998.

R. Arav-boger, M. Echavarria, M. Forman, P. Charache, and D. Persaud, Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient, Pediatr. Infect. Dis. J, vol.19, pp.1097-1100, 2000.

N. Arnberg, Adenovirus receptors: implications for tropism, treatment and targeting, Rev. Med. Virol, vol.19, pp.165-178, 2009.

N. Arnberg, K. Edlund, A. H. Kidd, and G. Wadell, Adenovirus Type 37 Uses Sialic Acid as a Cellular Receptor, J. Virol, vol.74, p.42, 2000.

I. Avivi, S. Chakrabarti, D. W. Milligan, H. Waldmann, G. Hale et al., Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab, Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant, vol.10, pp.186-194, 2004.

C. J. Bailey, R. G. Crystal, and P. L. Leopold, Association of adenovirus with the microtubule organizing center, J. Virol, vol.77, pp.13275-13287, 2003.

P. R. Barrero, L. E. Valinotto, E. Tittarelli, and A. S. Mistchenko, Molecular typing of adenoviruses in pediatric respiratory infections in, 1999.

, Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol, vol.53, pp.145-150

S. M. Berget, C. Moore, and P. A. Sharp, Spliced segments at the 5' terminus of adenovirus 2 late mRNA, Rev. Med. Virol, vol.10, pp.355-356, 1977.

A. J. Berk, Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene, vol.24, pp.7673-7685, 2005.

A. J. Berman, S. Kamtekar, J. L. Goodman, J. M. Lázaro, M. De-vega et al., Structures of phi29 DNA polymerase complexed with substrate: the mechanism of translocation in B-family polymerases, EMBO J, vol.26, pp.3494-3505, 2007.

A. Bernad, L. Blanco, J. M. Lázaro, G. Martín, and M. Salas, A conserved 3'----5' exonuclease active site in prokaryotic and eukaryotic DNA polymerases, Cell, vol.59, pp.219-228, 1989.

V. A. Bhadri, L. Lee-horn, and P. J. Shaw, Safety and tolerability of cidofovir in high-risk pediatric patients, Transpl. Infect. Dis. Off. J. Transplant. Soc, vol.11, pp.373-379, 2009.

P. Bordigoni, A. S. Carret, V. Venard, F. Witz, and A. Le-faou, Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.32, pp.1290-1297, 2001.

D. K. Braithwaite and J. Ito, Compilation, alignment, and phylogenetic relationships of DNA polymerases, Nucleic Acids Res, vol.21, pp.787-802, 1993.

K. H. Bremner, J. Scherer, J. Yi, M. Vershinin, S. P. Gross et al., Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit, Cell Host Microbe, vol.6, pp.523-535, 2009.

A. B. Brenkman, E. C. Breure, . Van-der, and P. C. Vliet, Molecular architecture of adenovirus DNA polymerase and location of the protein primer, J. Virol, vol.76, pp.8200-8207, 2002.

A. B. Brenkman, M. R. Heideman, V. Truniger, M. Salas, . Van-der et al., The (I/Y)XGG motif of adenovirus DNA polymerase affects template DNA binding and the transition from initiation to elongation, J. Biol. Chem, vol.276, pp.29846-29853, 2001.

B. Bruno, T. Gooley, R. C. Hackman, C. Davis, L. Corey et al., Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival, Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant, vol.9, pp.341-352, 2003.

S. P. Buckwalter, R. Teo, M. J. Espy, L. M. Sloan, T. F. Smith et al., Real-time qualitative PCR for 57 human adenovirus types from multiple specimen sources, J. Clin. Microbiol, vol.50, pp.766-771, 2012.

H. G. Burgert and J. H. Blusch, Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses, Virus Genes, vol.21, pp.13-25, 2000.

W. F. Cassano, Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation, Bone Marrow Transplant, vol.7, pp.247-248, 1991.

S. Chakrabarti, K. E. Collingham, C. D. Fegan, D. Pillay, and D. W. Milligan, Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy?, Bone Marrow Transplant, vol.26, pp.305-307, 2000.

S. Chakrabarti, V. Mautner, H. Osman, K. E. Collingham, C. D. Fegan et al., Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery, Blood, vol.100, pp.1619-1627, 2002.

C. Chartier, E. Degryse, M. Gantzer, A. Dieterle, A. Pavirani et al., Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli, J. Virol, vol.70, pp.4805-4810, 1996.

F. E. Chen, R. H. Liang, J. Y. Lo, K. Y. Yuen, T. K. Chan et al., Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir, Bone Marrow Transplant, vol.20, pp.997-999, 1997.

A. Choudhry, J. Mathena, J. D. Albano, M. Yacovone, and L. Collins, Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits, Vaccine, vol.34, pp.4558-4564, 2016.

L. C. Chow, R. E. Gelinas, T. R. Broker, and R. J. Roberts, An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA, Rev. Med. Virol, vol.10, pp.355-356, 1977.

T. Cihlar and M. S. Chen, Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells, Mol. Pharmacol, vol.50, pp.1502-1510, 1996.

S. Corjon, G. Gonzalez, P. Henning, A. Grichine, L. Lindholm et al., Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction, PloS One, vol.6, 2011.

R. Creidy, D. Moshous, F. Touzot, C. Elie, B. Neven et al., Specific T cells for the treatment of cytomegalovirus and/or adenovirus in the context of hematopoietic stem cell transplantation, J. Allergy Clin. Immunol, vol.138, pp.920-924, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01792617

K. C. Cundy, Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir, Clin. Pharmacokinet, vol.36, pp.127-143, 1999.

M. E. Curlin, M. Huang, X. Lu, C. L. Celum, J. Sanchez et al., Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men, PloS One, vol.5, 2010.

A. J. Davison, M. Benko, and B. Harrach, Genetic content and evolution of adenoviruses, 2003.

, J. Gen. Virol, vol.84, pp.2895-2908

E. De-clercq, Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox-and adenovirus) infections. Verh. -K. Acad. Voor Geneeskd. Van Belg, vol.58, pp.47-49, 1996.

D. Jong, J. C. Wermenbol, A. G. Verweij-uijterwaal, M. W. Slaterus, K. W. Wertheim-van-dillen et al., Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively, J. Clin. Microbiol, vol.37, pp.3940-3945, 1999.

C. B. De-oliveira, D. Stevenson, L. Labree, P. J. Mcdonnell, and M. D. Trousdale, Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model, Antiviral Res, vol.31, pp.165-172, 1996.

S. Dehghan, J. Seto, M. S. Jones, D. W. Dyer, J. Chodosh et al., Simian adenovirus type 35 has a recombinant genome comprising human and simian adenovirus sequences, which predicts its potential emergence as a human respiratory pathogen, Virology, vol.447, pp.265-273, 2013.

M. Delarue, O. Poch, N. Tordo, D. Moras, and P. Argos, An attempt to unify the structure of polymerases, Protein Eng, vol.3, pp.461-467, 1990.

O. Dominguez, P. Rojo, S. De-las-heras, D. Folgueira, and J. R. Contreras, Clinical presentation and characteristics of pharyngeal adenovirus infections, Pediatr. Infect. Dis. J, vol.24, pp.733-734, 2005.

E. R. Dubberke, B. Tu, D. J. Rivet, G. A. Storch, A. Apisarnthanarak et al., Acute meningoencephalitis caused by adenovirus serotype 26, J. Neurovirol, vol.12, pp.235-240, 2006.

B. A. Dudding, S. C. Wagner, J. A. Zeller, J. T. Gmelich, G. R. French et al., Fatal pneumonia associated with adenovirus type 7 in three military trainees, N. Engl. J. Med, vol.286, pp.1289-1292, 1972.

E. Dufour, J. Méndez, J. M. Lázaro, M. De-vega, L. Blanco et al., An aspartic acid residue in TPR-1, a specific region of protein-priming DNA polymerases, is required for the functional interaction with primer terminal protein, J. Mol. Biol, vol.304, pp.289-300, 2000.

J. M. Duggan, J. Farrehi, S. Duderstadt, N. J. Turner, and R. Fekety, Treatment with ganciclovir of adenovirus pneumonia in a cardiac transplant patient, Am. J. Med, vol.103, pp.439-440, 1997.

M. Dupuis, R. Hull, H. Wang, S. Nattanmai, B. Glasheen et al., Molecular detection of viral causes of encephalitis and meningitis in New York State, J. Med. Virol, vol.83, pp.2172-2181, 2011.

N. Durepaire, S. Ranger-rogez, J. A. Gandji, P. Weinbreck, J. P. Rogez et al., Enteric prevalence of adenovirus in human immunodeficiency virus seropositive patients, J. Med. Virol, vol.45, pp.56-60, 1995.

M. Echavarría, Adenoviruses in immunocompromised hosts, Clin. Microbiol. Rev, vol.21, pp.704-715, 2008.

B. Eiz-vesper, B. Maecker-kolhoff, and R. Blasczyk, Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry, Front. Immunol, vol.3, p.410, 2012.

J. F. Enders, J. A. Bell, J. H. Dingle, T. Francis, M. R. Hilleman et al., Adenoviruses: group name proposed for new respiratory-tract viruses, Science, vol.124, pp.119-120, 1956.

C. M. Evans, G. Kudesia, and M. Mckendrick, Management of herpesvirus infections, Int. J. Antimicrob. Agents, vol.42, pp.119-128, 2013.

L. Feghoul, S. Chevret, A. Cuinet, J. Dalle, M. Ouachée et al., Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.21, pp.701-709, 2015.

L. Feghoul, M. Salmona, J. Cherot, M. Fahd, J. Dalle et al., Evaluation of a New Device for Simplifying and Standardizing Stool Sample Preparation for Viral Molecular Testing with Limited Hands-On Time, J. Clin. Microbiol, vol.54, pp.928-933, 2016.

J. J. Feld, S. Nanda, Y. Huang, W. Chen, M. Cam et al., Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response, Hepatol. Baltim. Md, vol.46, pp.1548-1563, 2007.

R. Fernandez-larsson, K. O'connell, E. Koumans, and J. L. Patterson, Molecular analysis of the inhibitory effect of phosphorylated ribavirin on the vesicular stomatitis virus in vitro polymerase reaction, Antimicrob. Agents Chemother, vol.33, pp.1668-1673, 1989.

J. Feucht, K. Opherk, P. Lang, S. Kayser, L. Hartl et al., Adoptive Tcell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT, Blood, vol.125, 1986.

T. Feuchtinger, S. Matthes-martin, C. Richard, T. Lion, M. Fuhrer et al., Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation, Br. J. Haematol, vol.134, pp.64-76, 2006.

T. Feuchtinger, K. Opherk, W. A. Bethge, M. S. Topp, F. R. Schuster et al., Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation, Blood, vol.116, pp.4360-4367, 2010.

P. Flomenberg, J. Babbitt, W. R. Drobyski, R. C. Ash, D. R. Carrigan et al., Increasing incidence of adenovirus disease in bone marrow transplant recipients, J. Infect. Dis, vol.169, pp.775-781, 1994.

D. F. Florescu, S. A. Pergam, M. N. Neely, F. Qiu, C. Johnston et al., Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients, Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant, vol.18, pp.731-738, 2012.

D. Forstmeyer, C. Henke-gendo, V. Bröcker, O. Wildner, and A. Heim, Quantitative temporal and spatial distribution of adenovirus type 2 correlates with disease manifestations and organ failure during disseminated infection, J. Med. Virol, vol.80, pp.294-297, 2008.

H. M. Foy, M. K. Cooney, and J. B. Hatlen, Adenovirus type 3 epidemic associated with intermittent chlorination of a swimming pool, Arch. Environ. Health, vol.17, pp.795-802, 1968.

P. Frange, R. Peffault-de-latour, C. Arnaud, N. Boddaert, M. Oualha et al., Adenoviral infection presenting as an isolated central nervous system disease without detectable viremia in two children after stem cell transplantation, J. Clin. Microbiol, vol.49, pp.2361-2364, 2011.

M. C. Franklin, J. Wang, and T. A. Steitz, Structure of the replicating complex of a pol alpha family DNA polymerase, Cell, vol.105, pp.657-667, 2001.

T. Ganzenmueller, S. Buchholz, G. Harste, E. Dammann, R. Trenschel et al., High lethality of human adenovirus disease in adult allogeneic stem cell transplant recipients with high adenoviral blood load, J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol, vol.52, pp.55-59, 2011.

C. T. Garnett, D. Erdman, W. Xu, and L. R. Gooding, Prevalence and Quantitation of Species C Adenovirus DNA in Human Mucosal Lymphocytes, J. Virol, vol.76, pp.10608-10616, 2002.

C. T. Garnett, G. Talekar, J. A. Mahr, W. Huang, Y. Zhang et al., Latent species C adenoviruses in human tonsil tissues, J. Virol, vol.83, pp.2417-2428, 2009.

S. I. Gerber, D. D. Erdman, S. L. Pur, P. S. Diaz, J. Segreti et al., Outbreak of adenovirus genome type 7d2 infection in a pediatric chroniccare facility and tertiary-care hospital, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.32, pp.694-700, 2001.

A. N. Giberson, A. R. Davidson, and R. J. Parks, Chromatin structure of adenovirus DNA throughout infection, Nucleic Acids Res, vol.40, pp.2369-2376, 2012.

Y. J. Gordon, T. Araullo-cruz, E. Romanowski, B. Myers, D. Santora et al., Replication of ocular isolates of human adenovirus is serotype-dependent in rabbit corneal organ culture, Curr. Eye Res, vol.10, pp.267-271, 1991.

G. C. Gray, J. D. Callahan, A. W. Hawksworth, C. A. Fisher, and J. C. Gaydos, Respiratory diseases among U.S. military personnel: countering emerging threats, Emerg. Infect. Dis, vol.5, pp.379-385, 1999.

G. C. Gray, T. Mccarthy, M. G. Lebeck, D. P. Schnurr, K. L. Russell et al., Genotype prevalence and risk factors for severe clinical adenovirus infection, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.45, pp.1120-1131, 2004.

U. F. Greber, M. Willetts, P. Webster, and A. Helenius, Stepwise dismantling of adenovirus 2 during entry into cells, Cell, vol.75, pp.477-486, 1993.

M. S. Grimley, R. F. Chemaly, J. A. Englund, J. Kurtzberg, G. Chittick et al., Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial, Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant, vol.23, pp.512-521, 2017.

P. Hadaczek, T. Ozawa, L. Soroceanu, Y. Yoshida, L. Matlaf et al., Cidofovir: a novel antitumor agent for glioblastoma, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.19, pp.6473-6483, 2013.

F. A. Hakim and I. M. Tleyjeh, Severe adenovirus pneumonia in immunocompetent adults: a case report and review of the literature, Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol, vol.27, pp.153-158, 2008.

G. B. Harnett, P. A. Phillips, and M. M. Gollow, Association of genital adenovirus infection with urethritis in men, Med. J. Aust, vol.141, pp.337-338, 1984.

B. Harrach and M. Benko, Phylogenetic analysis of adenovirus sequences, Methods Mol. Med, vol.131, pp.299-334, 2007.

C. B. Hartline, K. M. Gustin, W. B. Wan, S. L. Ciesla, J. R. Beadle et al., Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro, J. Infect. Dis, vol.191, pp.396-399, 2005.

, nephritis associated with adenovirus infection, Hum. Pathol, vol.22, pp.1225-1231

B. F. Jaffe and H. F. Maassab, Sudden deafness associated with adenovirus infection, N. Engl. J. Med, vol.276, pp.1406-1409, 1967.

H. Jalal, D. F. Bibby, J. W. Tang, J. Bennett, C. Kyriakou et al., First reported outbreak of diarrhea due to adenovirus infection in a hematology unit for adults, J. Clin. Microbiol, vol.43, pp.2575-2580, 2005.

H. Jeulin, A. Salmon, P. Bordigoni, and V. Venard, Diagnostic value of quantitative PCR for adenovirus detection in stool samples as compared with antigen detection and cell culture in haematopoietic stem cell transplant recipients, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.17, 2011.

M. S. Jones, B. Harrach, R. D. Ganac, M. M. Gozum, D. Cruz et al., New adenovirus species found in a patient presenting with gastroenteritis, J. Virol, vol.81, pp.5978-5984, 2007.

I. Joung and J. A. Engler, Mutations in two cysteine-histidine-rich clusters in adenovirus type 2 DNA polymerase affect DNA binding, J. Virol, vol.66, pp.5788-5796, 1992.

I. Joung, M. S. Horwitz, and J. A. Engler, Mutagenesis of conserved region I in the DNA polymerase from human adenovirus serotype 2, Virology, vol.184, pp.235-241, 1991.

W. Kamel, B. Segerman, D. Öberg, T. Punga, and G. Akusjärvi, The adenovirus VA RNA-derived miRNAs are not essential for lytic virus growth in tissue culture cells, Nucleic Acids Res, vol.41, pp.4802-4812, 2013.

H. Kaneko, K. Aoki, S. Ishida, S. Ohno, N. Kitaichi et al., Recombination analysis of intermediate human adenovirus type 53 in Japan by complete genome sequence, J. Gen. Virol, vol.92, pp.1251-1259, 2011.

H. Kaneko, K. Kato, S. Mori, and S. Shigeta, Antiviral activity of NMSO3 against adenovirus in vitro, Antiviral Res, vol.52, pp.281-288, 2001.

S. H. Khoo, A. S. Bailey, J. C. De-jong, and B. K. Mandal, Adenovirus infections in human immunodeficiency virus-positive patients: clinical features and molecular epidemiology, J. Infect. Dis, vol.172, pp.629-637, 1995.

P. R. Kinchington, T. Araullo-cruz, J. Vergnes, K. Yates, and Y. J. Gordon, Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir, Antiviral Res, vol.56, pp.73-84, 2002.

A. J. King, W. R. Teertstra, L. Blanco, M. Salas, . Van-der et al., Processive proofreading by the adenovirus DNA polymerase. Association with the priming protein reduces exonucleolytic degradation, Nucleic Acids Res, vol.25, pp.1745-1752, 1997.

J. J. Kirsi, J. A. North, P. A. Mckernan, B. K. Murray, P. G. Canonico et al., Broad-spectrum antiviral activity of 2-beta-Dribofuranosylselenazole-4-carboxamide, a new antiviral agent, Antimicrob. Agents Chemother, vol.24, pp.353-361, 1983.

C. W. Knopf, Evolution of viral DNA-dependent DNA polymerases, Virus Genes, vol.16, pp.47-58, 1998.

E. Kodama, S. Shigeta, T. Suzuki, and E. De-clercq, Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method, Antiviral Res, vol.31, pp.159-164, 1996.

B. Koneru, R. Atchison, R. Jaffe, A. Cassavilla, D. H. Van-thiel et al., Serological studies of adenoviral hepatitis following pediatric liver transplantation, Transplant. Proc, vol.22, pp.1547-1548, 1990.

K. Kosulin, B. Berkowitsch, and T. Lion, Modified pan-adenovirus real-time PCR assay based on genome analysis of seventy HAdV types, J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol, vol.80, pp.60-61, 2016.

K. Kosulin, E. Geiger, A. Vécsei, W. Huber, M. Rauch et al., Persistence and reactivation of human adenoviruses in the gastrointestinal tract, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.22, 2016.

I. Kovesdi, D. E. Brough, J. T. Bruder, and T. J. Wickham, Adenoviral vectors for gene transfer, Curr. Opin. Biotechnol, vol.8, pp.583-589, 1997.

S. Kumar, G. Stecher, and K. Tamura, MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets, Mol. Biol. Evol, vol.33, pp.1870-1874, 2016.

L. Rosa, A. M. Champlin, R. E. Mirza, N. Gajewski, J. Giralt et al., Adenovirus infections in adult recipients of blood and marrow transplants, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.32, pp.871-876, 2001.

R. Lanier, Dedicated-to-Preventing-and-Treating-Life-Threatening-Viral-Infections, Presentation. Presented at the 55th, Interscience Conference on Antimicrobial And Chemotherapy, 2015.

Y. J. Lee, D. Chung, K. Xiao, E. B. Papadopoulos, J. N. Barker et al., Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution, Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant, vol.19, pp.387-392, 2013.

L. Lenaerts, E. De-clercq, and L. Naesens, Clinical features and treatment of adenovirus infections, Rev. Med. Virol, vol.18, pp.357-374, 2008.

L. Lenaerts and L. Naesens, Antiviral therapy for adenovirus infections, Antiviral Res, vol.71, pp.172-180, 2006.

P. L. Leopold and R. G. Crystal, Intracellular trafficking of adenovirus: many means to many ends, Adv. Drug Deliv. Rev, vol.59, pp.810-821, 2007.

M. Leruez-ville, M. Chardin-ouachée, B. Neven, C. Picard, I. Le-guinche et al., Description of an adenovirus A31 outbreak in a paediatric haematology unit, Bone Marrow Transplant, vol.38, pp.23-28, 2006.

D. L. Lichtenstein, K. Toth, K. Doronin, A. E. Tollefson, and W. S. Wold, Functions and mechanisms of action of the adenovirus E3 proteins, Int. Rev. Immunol, vol.23, pp.75-111, 2004.

C. A. Lindemans, A. M. Leen, and J. J. Boelens, How I treat adenovirus in hematopoietic stem cell transplant recipients, Blood, vol.116, pp.5476-5485, 2010.

T. Lion, Adenovirus Infections in Immunocompetent and Immunocompromised Patients, Clin. Microbiol. Rev, vol.27, pp.441-462, 2014.

T. Lion, R. Baumgartinger, F. Watzinger, S. Matthes-martin, M. Suda et al., Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease, Blood, vol.102, pp.1114-1120, 2003.

T. Lion, K. Kosulin, C. Landlinger, M. Rauch, S. Preuner et al., Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation, Leukemia, vol.24, pp.706-714, 2010.

H. Liu, J. H. Naismith, and R. T. Hay, Adenovirus DNA replication, Curr. Top. Microbiol. Immunol, vol.272, pp.131-164, 2003.

H. Liu, J. H. Naismith, and R. T. Hay, Identification of conserved residues contributing to the activities of adenovirus DNA polymerase, J. Virol, vol.74, pp.11681-11689, 2000.

H. Liu, L. Wu, and Z. H. Zhou, Model of the trimeric fiber and its interactions with the pentameric penton base of human adenovirus by cryo-electron microscopy, J. Mol. Biol, vol.406, pp.764-774, 2011.

L. Liu, Y. Qian, Y. Zhang, J. Deng, L. Jia et al., Adenoviruses associated with acute diarrhea in children in beijing, china, PloS One, vol.9, 2014.

P. Ljungman, P. Ribaud, M. Eyrich, S. Matthes-martin, H. Einsele et al., Infectious Diseases alpha v integrins for infection, J. Virol, vol.68, pp.6811-6814

Y. Matsushima, H. Shimizu, A. Kano, E. Nakajima, Y. Ishimaru et al., Genome sequence of a novel virus of the species human adenovirus d associated with acute gastroenteritis, Genome Announc, vol.1, 2013.

S. Matthes-martin, T. Feuchtinger, P. J. Shaw, D. Engelhard, H. H. Hirsch et al., European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4, Fourth European Conference on Infections in Leukemia, vol.14, pp.555-563, 2011.

D. A. Matthews and W. C. Russell, Adenovirus core protein V is delivered by the invading virus to the nucleus of the infected cell and later in infection is associated with nucleoli, J. Gen. Virol, vol.79, pp.1671-1675, 1998.

T. Matthews and R. Boehme, Antiviral activity and mechanism of action of ganciclovir, Rev. Infect. Dis, vol.10, pp.490-494, 1988.

T. Mccarthy, M. G. Lebeck, A. W. Capuano, D. P. Schnurr, and G. C. Gray, Molecular typing of clinical adenovirus specimens by an algorithm which permits detection of adenovirus coinfections and intermediate adenovirus strains, J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol, vol.46, pp.80-84, 2009.

O. Meier and U. F. Greber, Adenovirus endocytosis. J. Gene Med, vol.6, issue.1, pp.152-163, 2004.

M. G. Michaels, M. Green, E. R. Wald, and T. E. Starzl, Adenovirus infection in pediatric liver transplant recipients, J. Infect. Dis, vol.165, pp.170-174, 1992.

K. Miyamura, M. Hamaguchi, H. Taji, T. Kanie, A. Kohno et al., Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors, Bone Marrow Transplant, vol.25, pp.545-548, 2000.

V. Molinier-frenkel and P. Boulanger, Les adénovirus : de la structure à la vectorisation de gènes et à la vaccinologie. I. Virologie des adénovirus et des adénovirus recombinants, Virologie, vol.7, pp.267-279, 2003.

V. Montessori, S. Scharf, S. Holland, D. H. Werker, F. J. Roberts et al., Epidemic keratoconjunctivitis outbreak at a tertiary referral eye care clinic, Am. J. Infect. Control, vol.26, pp.399-405, 1998.

K. T. Montone, E. E. Furth, G. G. Pietra, and P. K. Gupta, Neonatal adenovirus infection: a case report with in situ hybridization confirmation of ascending intrauterine infection, Diagn. Cytopathol, vol.12, pp.341-344, 1995.

A. Moosmann, I. Bigalke, J. Tischer, L. Schirrmann, J. Kasten et al., Effective and long-term control of EBV PTLD after transfer of peptideselected T cells, Blood, vol.115, pp.2960-2970, 2010.

F. Morfin, S. Dupuis-girod, E. Frobert, S. Mundweiler, D. Carrington et al., Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone, Antivir. Ther, vol.14, pp.55-61, 2009.

F. Morfin, S. Dupuis-girod, S. Mundweiler, D. Falcon, D. Carrington et al., In vitro susceptibility of adenovirus to antiviral drugs is species-dependent, Antivir. Ther, vol.10, pp.225-229, 2005.

M. A. Mufson and R. B. Belshe, A review of adenoviruses in the etiology of acute hemorrhagic cystitis, J. Urol, vol.115, pp.191-194, 1976.

R. L. Myerowitz, H. Stalder, M. N. Oxman, M. J. Levin, M. Moore et al., Fatal disseminated adenovirus infection in a renal transplant recipient, Am. J. Med, vol.59, pp.591-598, 1975.

G. D. Myers, R. A. Krance, H. Weiss, I. Kuehnle, G. Demmler et al., Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath), Bone Marrow Transplant, vol.36, pp.1001-1008, 2005.

M. Mynarek, T. Ganzenmueller, A. Mueller-heine, C. Mielke, A. Gonnermann et al., Patient, virus, and treatment-related risk factors in pediatric adenovirus infection after stem cell transplantation: results of a routine monitoring program, Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant, vol.20, pp.250-256, 2014.

L. Naesens, L. Lenaerts, G. Andrei, R. Snoeck, D. Van-beers et al., Antiadenovirus activities of several classes of nucleoside and nucleotide analogues, Antimicrob. Agents Chemother, vol.49, pp.1010-1016, 2005.

M. Nakamura, E. Hirano, K. Kowada, F. Ishiguro, Z. Yamagishi et al., Surveillance of adenovirus D in patients with epidemic keratoconjunctivitis from Fukui Prefecture, J. Med. Virol, vol.84, pp.81-86, 1995.

R. C. Nauheim, E. G. Romanowski, T. Araullo-cruz, R. P. Kowalski, P. W. Turgeon et al., Prolonged recoverability of desiccated adenovirus type 19 from various surfaces, Ophthalmology, vol.97, pp.1450-1453, 1990.

G. R. Nemerow, P. L. Stewart, and V. S. Reddy, Structure of human adenovirus, Curr. Opin. Virol, vol.2, pp.115-121, 2012.

R. Neumann, E. Genersch, and H. J. Eggers, Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus, Virus Res, vol.7, pp.93-97, 1987.

E. C. Nilsson, R. J. Storm, J. Bauer, S. M. Johansson, A. Lookene et al., The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis, Nat. Med, vol.17, pp.105-109, 2011.

Q. Ning, D. Brown, J. Parodo, M. Cattral, R. Gorczynski et al., Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response, J. Immunol. Baltim. Md, vol.160, pp.3487-3493, 1950.

N. P. Ohori, M. G. Michaels, R. Jaffe, P. Williams, and S. A. Yousem, Adenovirus pneumonia in lung transplant recipients, Hum. Pathol, vol.26, pp.1073-1079, 1995.

T. Osamura, R. Mizuta, H. Yoshioka, and S. Fushiki, Isolation of adenovirus type 11 from the brain of a neonate with pneumonia and encephalitis, Eur. J. Pediatr, vol.152, pp.496-499, 1993.

D. Pagliara and B. Savoldo, Cytotoxic T lymphocytes for the treatment of viral infections and posttransplant lymphoproliferative disorders in transplant recipients, Curr. Opin. Infect. Dis, vol.25, pp.431-437, 2012.

G. R. Painter and K. Y. Hostetler, Design and development of oral drugs for the prophylaxis and treatment of smallpox infection, Trends Biotechnol, vol.22, pp.423-427, 2004.

W. Painter, A. Robertson, L. C. Trost, S. Godkin, B. Lampert et al., First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses, Antimicrob. Agents Chemother, vol.56, pp.2726-2734, 2012.

K. Paolino, J. Sande, E. Perez, B. Loechelt, B. Jantausch et al., Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001, J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol, vol.50, pp.167-170, 2011.

S. Parker, L. Handley, and R. M. Buller, Therapeutic and prophylactic drugs to treat orthopoxvirus infections, Future Virol, vol.3, pp.595-612, 2008.

O. M. Pello, A. J. Innes, A. Bradshaw, S. Finn, S. Uddin et al., BKV-specific T cells in the treatment of severe refractory haemorrhagic cystitis after HLA-haploidentical haematopoietic cell transplantation, Eur. J. Haematol, vol.98, pp.632-634, 2017.

P. Perez-romero, K. E. Gustin, and M. J. Imperiale, Dependence of the encapsidation function of the adenovirus L1 52/55-kilodalton protein on its ability to bind the packaging sequence, J. Virol, vol.80, 1965.

E. Ponterio and L. Gnessi, Adenovirus 36 and Obesity: An Overview, Viruses, vol.7, pp.3719-3740, 2015.

W. Qasim, K. Gilmour, H. Zhan, S. Derniame, A. M. Mcnicol et al., Interferon-? capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation, Br. J. Haematol, vol.161, pp.449-452, 2013.

C. Qian, A. Campidelli, Y. Wang, H. Cai, V. Venard et al., Curative or preemptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial, J. Hematol. Oncol.J Hematol Oncol, vol.10, p.102, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01720707

D. C. Quenelle, B. Lampert, D. J. Collins, T. L. Rice, G. R. Painter et al., Efficacy of CMX001 against herpes simplex virus infections in mice and correlations with drug distribution studies, J. Infect. Dis, vol.202, pp.1492-1499, 2010.

J. M. Radin, A. W. Hawksworth, P. E. Kammerer, M. Balansay, R. Raman et al., Epidemiology of pathogen-specific respiratory infections among three US populations, PloS One, vol.9, 2014.

M. Robin, S. Marque-juillet, C. Scieux, R. Peffault-de-latour, C. Ferry et al., Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome, Haematologica, vol.92, pp.1254-1257, 2007.

C. M. Robinson, J. Rajaiya, X. Zhou, G. Singh, D. W. Dyer et al., The E3 CR1-gamma gene in human adenoviruses associated with epidemic keratoconjunctivitis, Virus Res, vol.160, pp.120-127, 2011.

C. M. Robinson, D. Seto, M. S. Jones, D. W. Dyer, and J. Chodosh, Molecular evolution of human species D adenoviruses, Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis, vol.11, pp.1208-1217, 2011.

C. M. Robinson, G. Singh, J. Y. Lee, S. Dehghan, J. Rajaiya et al., Molecular evolution of human adenoviruses, Sci. Rep, vol.3, p.1812, 2013.

I. Rodríguez, J. M. Lázaro, L. Blanco, S. Kamtekar, A. J. Berman et al., A specific subdomain in phi29 DNA polymerase confers both processivity and strand-displacement capacity, Proc. Natl. Acad. Sci. U. S. A, vol.102, pp.6407-6412, 2005.

P. J. Rothwell and G. Waksman, Structure and mechanism of DNA polymerases, Adv. Protein Chem, vol.71, pp.401-440, 2005.

W. P. Rowe, R. J. Huebner, L. K. Gilmore, R. H. Parrott, and T. G. Ward, Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture, Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. N. Y. N, vol.84, pp.570-573, 1953.

S. Roy, R. Calcedo, A. Medina-jaszek, M. Keough, H. Peng et al., Adenoviruses in lymphocytes of the human gastro-intestinal tract, PloS One, vol.6, 2011.

K. L. Russell, M. P. Broderick, S. E. Franklin, L. B. Blyn, N. E. Freed et al., Transmission dynamics and prospective environmental sampling of adenovirus in a military recruit setting, J. Infect. Dis, vol.194, pp.877-885, 2006.

W. C. Russell, Adenoviruses: update on structure and function, J. Gen. Virol, vol.90, 2009.

W. A. Rutala, J. E. Peacock, M. F. Gergen, M. D. Sobsey, and D. J. Weber, Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities, Antimicrob. Agents Chemother, vol.50, pp.1419-1424, 2006.

R. P. Sambursky, N. Fram, and E. J. Cohen, The prevalence of adenoviral conjunctivitis at the Wills Eye Hospital Emergency Room, vol.78, pp.236-239, 2007.

H. Sarantis, G. Johnson, M. Brown, M. Petric, and R. Tellier, Comprehensive detection and serotyping of human adenoviruses by PCR and sequencing, J. Clin. Microbiol, vol.42, pp.3963-3969, 2004.

A. Sauerbrei, K. Bohn-wippert, M. Kaspar, A. Krumbholz, M. Karrasch et al., Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2, J. Antimicrob. Chemother, vol.71, pp.6-16, 2016.

J. Scherer and R. B. Vallee, Adenovirus recruits dynein by an evolutionary novel mechanism involving direct binding to pH-primed hexon, Viruses, vol.3, pp.1417-1431, 2011.

W. Schneider-brachert, V. Tchikov, O. Merkel, M. Jakob, C. Hallas et al., Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism, J. Clin. Invest, vol.116, pp.2901-2913, 2006.

S. Schreiner, P. Wimmer, H. Sirma, R. D. Everett, P. Blanchette et al., Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells, J. Virol, vol.84, pp.7029-7038, 2010.

M. Sester, K. Koebernick, D. Owen, M. Ao, Y. Bromberg et al., Conserved amino acids within the adenovirus 2 E3/19K protein differentially affect downregulation of MHC class I and MICA/B proteins, J. Immunol. Baltim. Md, vol.184, pp.255-267, 1950.

P. Sethna, A. Bae, D. Selleseth, and R. Lanier, In vitro selection of brincidofovir-resistant and cidofovir-resistant human adenovirus, Poster. Presented at the 27th International Conference on Antiviral Research (ICAR), 2014.

P. Sethna, A. Bae, D. Selleseth, and R. Lanier, In-Vitro-Selection-of-BrincidofovirResistant-and-Cidofovir-Resistant-Human-Adenovirus, 2014.

I. V. Shevelev and U. Hübscher, The 3' 5' exonucleases, Nat. Rev. Mol. Cell Biol, vol.3, pp.364-376, 2002.

G. S. Shirali, J. Ni, R. E. Chinnock, J. K. Johnston, G. L. Rosenthal et al., Association of viral genome with graft loss in children after cardiac transplantation, N. Engl. J. Med, vol.344, pp.1498-1503, 2001.

R. W. Sidwell, J. H. Huffman, G. P. Khare, L. B. Allen, J. T. Witkowski et al., Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide, Science, vol.177, pp.705-706, 1972.

S. Similä, R. Jouppila, A. Salmi, and R. Pohjonen, Encephaloningitis in children associated with an adenovirus type 7 epidemic, Acta Paediatr. Scand, vol.59, pp.310-316, 1970.

J. G. Smith, C. M. Wiethoff, P. L. Stewart, and G. R. Nemerow, Adenovirus. Curr. Top. Microbiol. Immunol, vol.343, pp.195-224, 2010.

M. A. South, J. Dolen, D. K. Beach, and R. R. Mirkovic, Fatal adenovirus hepatic necrosis in severe combined immune deficiency, Pediatr. Infect. Dis, vol.1, pp.416-419, 1982.

P. L. Stewart, S. D. Fuller, and R. M. Burnett, Difference imaging of adenovirus: bridging the resolution gap between X-ray crystallography and electron microscopy, EMBO J, vol.12, pp.2589-2599, 1993.

N. Sun, W. Zhong, S. Lu, Y. Tian, J. Chen et al., Coexpression of recombinant adenovirus carrying GDNF and EDNRB genes in neural stem cells in vitro, Cell Biol. Int, vol.37, pp.458-463, 2013.

M. Suomalainen, M. Y. Nakano, S. Keller, K. Boucke, R. P. Stidwill et al., Microtubule-dependent plus-and minus end-directed motilities are competing processes for nuclear targeting of adenovirus, J. Cell Biol, vol.144, pp.657-672, 1999.

C. Suparno, D. W. Milligan, P. A. Moss, and V. Mautner, Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, 2004.

M. P. Walsh, J. Seto, E. B. Liu, S. Dehghan, N. R. Hudson et al., Computational analysis of two species C human adenoviruses provides evidence of a novel virus, J. Clin. Microbiol, vol.49, pp.3482-3490, 2011.

H. Wang, Z. Li, R. Yumul, S. Lara, A. Hemminki et al., Multimerization of adenovirus serotype 3 fiber knob domains is required for efficient binding of virus to desmoglein 2 and subsequent opening of epithelial junctions, J. Virol, vol.85, pp.6390-6402, 2011.

Y. Wang, Y. Li, R. Lu, Y. Zhao, Z. Xie et al., Phylogenetic evidence for intratypic recombinant events in a novel human adenovirus C that causes severe acute respiratory infection in children, Sci. Rep, vol.6, p.23014, 2016.

D. Wevers, S. Metzger, F. Babweteera, M. Bieberbach, C. Boesch et al., Novel adenoviruses in wild primates: a high level of genetic diversity and evidence of zoonotic transmissions, J. Virol, vol.85, pp.10774-10784, 2011.

C. M. Wiethoff, H. Wodrich, L. Gerace, and G. R. Nemerow, Adenovirus protein VI mediates membrane disruption following capsid disassembly, J. Virol, vol.79, 1992.

O. Wildner, D. Hoffmann, C. Jogler, and K. Uberla, Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs, Cancer Gene Ther, vol.10, pp.791-802, 2003.

H. Wodrich, A. Cassany, M. A. D'angelo, T. Guan, G. Nemerow et al., Adenovirus core protein pVII is translocated into the nucleus by multiple import receptor pathways, J. Virol, vol.80, pp.9608-9618, 2006.
URL : https://hal.archives-ouvertes.fr/hal-02262475

J. Xu, L. Lin, M. Yong, X. Dong, T. Yu et al., Adenovirus-mediated overexpression of cystic fibrosis transmembrane conductance regulator enhances invasiveness and motility of serous ovarian cancer cells, Mol. Med. Rep, vol.13, pp.265-272, 2016.

Y. Yabe, J. J. Trentin, and G. Taylor, Cancer induction in hamsters by human type 12, 1962.

, Effect of age and of virus dose, Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. N. Y. N, vol.111, pp.343-344

S. T. Yabiku, M. M. Yabiku, K. M. Bottós, A. L. Araújo, D. Freitas et al., , 2011.

, Arq. Bras. Oftalmol, vol.74, pp.417-421

B. Ying, A. E. Tollefson, J. F. Spencer, L. Balakrishnan, S. Dewhurst et al., Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters, Antimicrob. Agents Chemother, vol.58, pp.7171-7181, 2014.

B. W. Yoon, Y. G. Song, and S. H. Lee, Severe community-acquired adenovirus pneumonia treated with oral ribavirin: a case report, BMC Res. Notes, vol.10, p.47, 2017.

U. Yusuf, G. A. Hale, J. Carr, Z. Gu, E. Benaim et al., Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients, Transplantation, vol.81, pp.1398-1404, 2006.

J. M. Zahradnik, Adenovirus pneumonia, Semin. Respir. Infect, vol.2, pp.104-111, 1987.

W. Zhang, J. A. Low, J. B. Christensen, and M. J. Imperiale, Role for the adenovirus IVa2 protein in packaging of viral DNA, J. Virol, vol.75, pp.10446-10454, 2001.

L. J. Zhao and R. Padmanabhan, Nuclear transport of adenovirus DNA polymerase is facilitated by interaction with preterminal protein, Cell, vol.55, pp.1005-1015, 1988.

S. Zhou, R. Liu, B. M. Baroudy, B. A. Malcolm, and G. R. Reyes, The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA, Virology, vol.310, pp.333-342, 2003.

C. Zubieta, G. Schoehn, J. Chroboczek, and S. Cusack, The structure of the human adenovirus 2 penton, Mol. Cell, vol.17, pp.121-135, 2005.

, Jennifer Richardson, vol.3

, APHP

, Hematology Department

A. Upe, E. Inra, . Inra/enva, and F. Maisons-alfort, Running title: Human Adenovirus DNA polymerase polymorphism Corresponding author Dr Jérôme Le Goff Laboratoire de Microbiologie, p.33

A. Qurashi, Y. M. Guiver, M. Cooper, and R. J. , Sequence typing of adenovirus from samples from hematological stem cell transplant recipients, J. Med. Virol, vol.83, pp.1951-1958, 2011.

K. A. Aldern, S. L. Ciesla, K. L. Winegarden, and K. Y. Hostetler, Increased antiviral activity of 1-Ohexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism, Mol. Pharmacol, vol.63, pp.678-681, 2003.

G. Andrei, R. Snoeck, J. Piette, P. Delvenne, and E. De-clercq, Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPVnegative cell lines, Oncol. Res, vol.10, pp.523-531, 1998.

N. Arnberg, Adenovirus receptors: implications for tropism, treatment and targeting, Rev. Med. Virol, vol.19, pp.165-178, 2009.

N. Arnberg, K. Edlund, A. H. Kidd, and G. Wadell, Adenovirus Type 37 Uses Sialic Acid as a Cellular Receptor, J. Virol, vol.74, p.42, 2000.

C. J. Bailey, R. G. Crystal, and P. L. Leopold, Association of adenovirus with the microtubule organizing center, J. Virol, vol.77, pp.13275-13287, 2003.

P. R. Barrero, L. E. Valinotto, E. Tittarelli, and A. S. Mistchenko, Molecular typing of adenoviruses in pediatric respiratory infections in, J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol, vol.53, pp.145-150, 1999.

S. M. Berget, C. Moore, and P. A. Sharp, Spliced segments at the 5' terminus of adenovirus 2 late mRNA, Rev. Med. Virol, vol.10, pp.355-356, 1977.

A. J. Berk, Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene, vol.24, pp.7673-7685, 2005.

A. J. Berman, S. Kamtekar, J. L. Goodman, J. M. Lázaro, M. De-vega et al., Structures of phi29 DNA polymerase complexed with substrate: the mechanism of translocation in Bfamily polymerases, EMBO J, vol.26, pp.3494-3505, 2007.

A. Bernad, L. Blanco, J. M. Lázaro, G. Martín, and M. Salas, A conserved 3'----5' exonuclease active site in prokaryotic and eukaryotic DNA polymerases, Cell, vol.59, pp.219-228, 1989.

V. A. Bhadri, L. Lee-horn, and P. J. Shaw, Safety and tolerability of cidofovir in high-risk pediatric patients, Transpl. Infect. Dis. Off. J. Transplant. Soc, vol.11, pp.373-379, 2009.

D. K. Braithwaite and J. Ito, Compilation, alignment, and phylogenetic relationships of DNA polymerases, Nucleic Acids Res, vol.21, pp.787-802, 1993.

A. B. Brenkman, E. C. Breure, . Van-der, and P. C. Vliet, Molecular architecture of adenovirus DNA polymerase and location of the protein primer, J. Virol, vol.76, pp.8200-8207, 2002.

H. G. Burgert and J. H. Blusch, Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses, Virus Genes, vol.21, pp.13-25, 2000.

W. F. Cassano, Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation, Bone Marrow Transplant, vol.7, pp.247-248, 1991.

F. E. Chen, R. H. Liang, J. Y. Lo, K. Y. Yuen, T. K. Chan et al., Treatment of adenovirusassociated haemorrhagic cystitis with ganciclovir, Bone Marrow Transplant, vol.20, pp.997-999, 1997.

A. Choudhry, J. Mathena, J. D. Albano, M. Yacovone, and L. Collins, Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits, Vaccine, vol.34, pp.4558-4564, 2016.

L. C. Chow, R. E. Gelinas, T. R. Broker, and R. J. Roberts, An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA, Rev. Med. Virol, vol.10, pp.355-356, 1977.

K. C. Cundy, Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir, Clin. Pharmacokinet, vol.36, pp.127-143, 1999.

M. E. Curlin, M. Huang, X. Lu, C. L. Celum, J. Sanchez et al., Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men, PloS One, vol.5, 2010.

A. J. Davison, M. Benko, and B. Harrach, Genetic content and evolution of adenoviruses, J. Gen. Virol, vol.84, pp.2895-2908, 2003.

D. Jong, J. C. Wermenbol, A. G. Verweij-uijterwaal, M. W. Slaterus, K. W. Wertheim-van-dillen et al., Adenoviruses from human immunodeficiency virusinfected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively, J. Clin. Microbiol, vol.37, pp.3940-3945, 1999.

M. Delarue, O. Poch, N. Tordo, D. Moras, and P. Argos, An attempt to unify the structure of polymerases, Protein Eng, vol.3, pp.461-467, 1990.

E. R. Dubberke, B. Tu, D. J. Rivet, G. A. Storch, A. Apisarnthanarak et al., Acute meningoencephalitis caused by adenovirus serotype 26, J. Neurovirol, vol.12, pp.235-240, 2006.

J. M. Duggan, J. Farrehi, S. Duderstadt, N. J. Turner, and R. Fekety, Treatment with ganciclovir of adenovirus pneumonia in a cardiac transplant patient, Am. J. Med, vol.103, pp.439-440, 1997.

M. Dupuis, R. Hull, H. Wang, S. Nattanmai, B. Glasheen et al., Molecular detection of viral causes of encephalitis and meningitis in New York State, J. Med. Virol, vol.83, pp.2172-2181, 2011.

M. Echavarría, Adenoviruses in immunocompromised hosts, Clin. Microbiol. Rev, vol.21, pp.704-715, 2008.

J. F. Enders, J. A. Bell, J. H. Dingle, T. Francis, M. R. Hilleman et al., Adenoviruses: group name proposed for new respiratory-tract viruses, Science, vol.124, pp.119-120, 1956.

C. M. Evans, G. Kudesia, and M. Mckendrick, Management of herpesvirus infections, Int. J. Antimicrob. Agents, vol.42, pp.119-128, 2013.

L. Feghoul, S. Chevret, A. Cuinet, J. Dalle, M. Ouachée et al., Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral preemptive treatment, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.21, pp.701-709, 2015.

J. Feucht, K. Opherk, P. Lang, S. Kayser, L. Hartl et al., Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT, Blood, vol.125, 1986.

H. M. Foy, M. K. Cooney, and J. B. Hatlen, Adenovirus type 3 epidemic associated with intermittent chlorination of a swimming pool, Arch. Environ. Health, vol.17, pp.795-802, 1968.

M. C. Franklin, J. Wang, and T. A. Steitz, Structure of the replicating complex of a pol alpha family DNA polymerase, Cell, vol.105, pp.657-667, 2001.

, J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol, vol.52, pp.55-59

C. T. Garnett, D. Erdman, W. Xu, and L. R. Gooding, Prevalence and Quantitation of Species C Adenovirus DNA in Human Mucosal Lymphocytes, J. Virol, vol.76, pp.10608-10616, 2002.

C. T. Garnett, G. Talekar, J. A. Mahr, W. Huang, Y. Zhang et al., Latent species C adenoviruses in human tonsil tissues, J. Virol, vol.83, pp.2417-2428, 2009.

S. I. Gerber, D. D. Erdman, S. L. Pur, P. S. Diaz, J. Segreti et al., Outbreak of adenovirus genome type 7d2 infection in a pediatric chronic-care facility and tertiary-care hospital, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.32, pp.694-700, 2001.

A. N. Giberson, A. R. Davidson, and R. J. Parks, Chromatin structure of adenovirus DNA throughout infection, Nucleic Acids Res, vol.40, pp.2369-2376, 2012.

U. F. Greber, M. Willetts, P. Webster, and A. Helenius, Stepwise dismantling of adenovirus 2 during entry into cells, Cell, vol.75, pp.477-486, 1993.

P. Hadaczek, T. Ozawa, L. Soroceanu, Y. Yoshida, L. Matlaf et al., Cidofovir: a novel antitumor agent for glioblastoma, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.19, pp.6473-6483, 2013.

G. B. Harnett, P. A. Phillips, and M. M. Gollow, Association of genital adenovirus infection with urethritis in men, Med. J. Aust, vol.141, pp.337-338, 1984.

B. Harrach and M. Benko, Phylogenetic analysis of adenovirus sequences, Methods Mol. Med, vol.131, pp.299-334, 2007.

J. C. Hierholzer, Adenoviruses in the immunocompromised host, Clin. Microbiol. Rev, vol.5, pp.262-274, 1992.

J. C. Hierholzer, R. Wigand, L. J. Anderson, T. Adrian, and J. W. Gold, Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47), J. Infect. Dis, vol.158, pp.804-813, 1988.

M. R. Hilleman and J. H. Werner, Recovery of new agent from patients with acute respiratory illness, Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. N. Y. N, vol.85, pp.183-188, 1954.

H. T. Ho, K. L. Woods, J. J. Bronson, H. De-boeck, J. C. Martin et al., Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, Mol. Pharmacol, vol.41, pp.197-202, 1992.

R. C. Hoeben and T. G. Uil, Adenovirus DNA replication, Cold Spring Harb. Perspect. Biol, vol.5, p.13003, 2013.

J. Y. Hong, H. J. Lee, P. A. Piedra, E. H. Choi, K. H. Park et al., Lower respiratory tract infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.32, pp.1423-1429, 2001.

S. S. Hong, L. Karayan, J. Tournier, D. T. Curiel, and P. A. Boulanger, Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells, EMBO J, vol.16, pp.2294-2306, 1997.

K. Y. Hostetler, S. Rought, K. A. Aldern, J. Trahan, J. R. Beadle et al., Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro, Mol. Cancer Ther, vol.5, pp.156-159, 2006.

R. Hromas, K. Cornetta, E. Srour, C. Blanke, and E. R. Broun, Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation, Blood, vol.84, pp.1689-1690, 1994.

G. Huang and W. Xu, , 2013.

B. Chin, J. Virol, vol.29, pp.342-348

J. Y. Hwang, K. M. Lee, Y. H. Kim, H. M. Shim, Y. K. Bae et al., Pregnancy Loss Following Coxsackievirus B3 Infection in Mice during Early Gestation Due toHigh Expression of Coxsackievirus-Adenovirus Receptor (CAR) in Uterus and Embryo, Exp. Anim. Jpn. Assoc. Lab. Anim, 2014.

. Sci, , vol.63, pp.63-72

V. Icheva, S. Kayser, D. Wolff, S. Tuve, C. Kyzirakos et al., Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.31, pp.39-48, 2013.

M. Ito, N. Hirabayashi, Y. Uno, A. Nakayama, and J. Asai, Necrotizing tubulointerstitial nephritis associated with adenovirus infection, Hum. Pathol, vol.22, pp.1225-1231, 1991.

B. F. Jaffe and H. F. Maassab, Sudden deafness associated with adenovirus infection, N. Engl. J. Med, vol.276, pp.1406-1409, 1967.

M. S. Jones, B. Harrach, R. D. Ganac, M. M. Gozum, D. Cruz et al., New adenovirus species found in a patient presenting with gastroenteritis, J. Virol, vol.81, pp.5978-5984, 2007.

I. Joung and J. A. Engler, Mutations in two cysteine-histidine-rich clusters in adenovirus type 2 DNA polymerase affect DNA binding, J. Virol, vol.66, pp.5788-5796, 1992.

I. Joung, M. S. Horwitz, and J. A. Engler, Mutagenesis of conserved region I in the DNA polymerase from human adenovirus serotype 2, Virology, vol.184, pp.235-241, 1991.

H. Kaneko, K. Kato, S. Mori, and S. Shigeta, Antiviral activity of NMSO3 against adenovirus in vitro, Antiviral Res, vol.52, pp.281-288, 2001.

J. J. Kirsi, J. A. North, P. A. Mckernan, B. K. Murray, P. G. Canonico et al., Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent, Antimicrob. Agents Chemother, vol.24, pp.353-361, 1983.

C. W. Knopf, Evolution of viral DNA-dependent DNA polymerases, Virus Genes, vol.16, pp.47-58, 1998.

E. Kodama, S. Shigeta, T. Suzuki, and E. De-clercq, Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method, Antiviral Res, vol.31, pp.159-164, 1996.

I. Kovesdi, D. E. Brough, J. T. Bruder, and T. J. Wickham, Adenoviral vectors for gene transfer, Curr. Opin. Biotechnol, vol.8, pp.583-589, 1997.

S. Kumar, G. Stecher, and K. Tamura, MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets, Mol. Biol. Evol, vol.33, pp.1870-1874, 2016.

R. Lanier, Dedicated-to-Preventing-and-Treating-Life-Threatening-Viral-Infections, Presentation. Presented at the 55th, Interscience Conference on Antimicrobial And Chemotherapy, 2015.

Y. J. Lee, D. Chung, K. Xiao, E. B. Papadopoulos, J. N. Barker et al., Adenovirus viremia and disease: comparison of T celldepleted and conventional hematopoietic stem cell transplantation recipients from a single institution, Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant, vol.19, pp.387-392, 2013.